NCT06036407 2026-04-14
HEAR
University of Bern
Phase NA Completed
Clinical Trials
6 trialsNCT05789316 2026-01-12
Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)
Washington University School of Medicine
Phase NA Completed
NCT05936034 2025-11-28
PROTOTOX
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT06957132 2025-05-04
RISP-OTOTOX
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Not yet recruiting
NCT03400709 2018-01-17
Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer
Hospital San Juan de Dios, Santiago
Phase NA Completed
NCT02382068 2017-11-09
Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn